A natural product-like inhibitor of NEDD8-activating enzyme.

The natural product-like 6,6″-biapigenin has been identified as only the second inhibitor of NEDD8-activating enzyme using virtual screening. This compound was active in enzyme and cell-based assays, with potency in the micromolar range.

[1]  Fa-ching Chen,et al.  Succedaneaflavanone—a new 6,6″-binaringenin from Rhus succedanea , 1975 .

[2]  R Abagyan,et al.  Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.

[3]  E. Gonçalez,et al.  Biflavonoids inhibit the production of aflatoxin by Aspergillus flavus. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  C. Cassidy,et al.  Biflavonoids as novel antituberculosis agents. , 2001, Bioorganic & medicinal chemistry letters.

[5]  Jürgen Bajorath,et al.  Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[6]  W. Kaelin,et al.  An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cells , 2002, EMBO reports.

[7]  R. Firn,et al.  Natural products--a simple model to explain chemical diversity. , 2003, Natural product reports.

[8]  David W. Miller,et al.  The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. , 2003, Molecular cell.

[9]  J. Adams,et al.  Development of the Proteasome Inhibitor Velcade™ (Bortezomib) , 2004, Cancer investigation.

[10]  D. C. Dias,et al.  Nedd8 on cullin: building an expressway to protein destruction , 2004, Oncogene.

[11]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[12]  Hiroshi Yasui,et al.  A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. , 2005, Cancer cell.

[13]  P. Richardson,et al.  Bortezomib: proteasome inhibition as an effective anticancer therapy. , 2005, Future oncology.

[14]  U. Desai,et al.  Synthesis of Biologically Relevant Biflavanoids – A Review , 2007, Chemistry & biodiversity.

[15]  W. Vilegas,et al.  An unusual C6-C6" linked flavonoid from Miconia cabucu (Melastomataceae). , 2007, Phytochemistry.

[16]  L. Mueller-Kuhrt.  Successful, but often unconventional: the continued and long-term contribution of natural products to healthcare , 2007, Expert opinion on drug discovery.

[17]  R. Abagyan,et al.  Discovery of a Drug‐Like G‐Quadruplex Binding Ligand by High‐Throughput Docking , 2008, ChemMedChem.

[18]  J. Vederas,et al.  Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.

[19]  U. Testa.  Proteasome inhibitors in cancer therapy. , 2009, Current drug targets.

[20]  Amanda Doucette,et al.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.

[21]  Peter G. Smith,et al.  Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer , 2009, Clinical Cancer Research.

[22]  Fang Yang,et al.  Identification of natural product fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. , 2010, Chemical communications.

[23]  Ping Li,et al.  Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. , 2010, Molecular cell.

[24]  Francis J Giles,et al.  Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. , 2010, Blood.

[25]  R. Abagyan,et al.  Structure-based discovery of natural-product-like TNF-α inhibitors. , 2010, Angewandte Chemie.